Preferred test to confirm respiratory syncytial virus (RSV) or influenza in general inpatients and RSV in adults.
Qualitative Reverse Transcription Polymerase Chain Reaction
New York DOH Approval Status
Respiratory specimen: Bronchoalveolar lavage (BAL), nasal wash, nasopharyngeal swab, or pleural fluid.
Fluid: Transfer 1 mL respiratory specimen to a sterile container. (Min: 0.5 mL) Also acceptable: Transfer to viral transport media (ARUP Supply #12884). Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. Swabs: Place in viral transport media. Place each specimen in an individually sealed bag.
Specimen source required.
Ambient: 8 hours; Refrigerated: 5 days; Frozen: 2 months
|Influenza A by PCR||Negative|
|Influenza B by PCR||Negative|
|RSV by PCR||Negative|
A negative result does not rule out the presence of PCR inhibitors in the patient specimen or assay specific nucleic acid in concentrations below the level of detection by the assay.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Depends on Specimen/Source/Method
|Component Test Code*||Component Chart Name||LOINC|
|0060765||Influenza A by PCR||34487-9|
|0060766||Influenza B by PCR||40982-1|
|0060767||RSV by PCR||40988-8|
- Influenza A and B
- Influenza A PCR
- Influenza B PCR
- Respiratory Syncytial Virus
- RSV Molecular Detection, PCR
- RSV PCR